Related Experiment Video
Updated: Jul 3, 2026
03:49
Application of Microwave Ablation in Laparoscopic Partial Splenectomy
Published on: November 15, 2024
From hamartoma to splenic hemangioma
Joanna Szpor1, Grzegorz Dyduch
1Department of Pathomorphology, Collegium Medicum, Jagiellonian University, Kraków.
Summary
The spleen can develop benign vascular tumors, presenting diagnostic challenges due to varied appearances. This study identifies and characterizes eight such splenic vascular lesions, including hemangiomas, hamartomas, and sclerosing angiomatoid nodular transformation (SANT).
Area of Science:
- Pathology
- Oncology
- Vascular Biology
Background:
- Benign vascular lesions are the most common primary non-hematological tumors of the spleen.
- Their morphologic heterogeneity can complicate differential diagnosis.
Observation:
- A retrospective analysis of splenic vascular lesions from the Chair of Pathomorphology archive was conducted.
- Immunohistochemistry was performed using markers including CD34, CD31, factor VIII, and GLUT-1.
Findings:
- Eight benign vascular splenic lesions were identified.
- These included two splenic hamartomas, two sclerosing angiomatoid nodular transformation (SANT) lesions, and four splenic hemangiomas.
Implications:
- This study highlights the spectrum of benign vascular splenic lesions.
- Understanding their characteristics is crucial for accurate differential diagnosis and classification of splenic tumors.
Related Concept Videos
01:19Multipotency of Hematopoietic Stem Cells
The hematopoietic stem cells or HSCs are multipotent, meaning they can differentiate and give rise to all blood and immune cells. HSCs are maintained in the quiescent stage until an external stimulus initiates their differentiation. The multipotent HSCs exist as two heterogeneous populations, long-term repopulating cells (LTRC) and short-term repopulating cells (STRC). The two HSC populations have different surface markers or receptors and are classified based on quiescence and long-term...
01:21Hematopoiesis
The process of blood cell formation is called hematopoiesis. Hematopoiesis starts early during development, on the seventh day of embryogenesis. This phase of hematopoiesis is called the primitive wave, wherein the extraembryonic yolk sac allows the production of erythroid cells and endothelial cells from a common precursor called hemangioblast. The erythroid cells provide oxygen to support the growth of the rapidly dividing embryo. Hemangioblasts later develop into hematopoietic stem cells or...
01:17Hemorrhagic Stroke l: Introduction
A hemorrhagic stroke is an acute neurological event that occurs when a weakened cerebral blood vessel ruptures, allowing blood to accumulate within or around the brain. The sudden release of blood forms a focal hematoma that increases intracranial pressure, displaces neural tissue, and can obstruct cerebrospinal fluid pathways. These effects may be compounded by intraventricular extension of the hemorrhage, cerebral edema, or compression of adjacent structures, all of which contribute to...
01:34Production of Formed Elements
Hemangioblasts are multipotent stem cells originating from the mesoderm. They give rise to hematopoietic stem cells (HSCs), which undergo hematopoiesis to produce all the formed elements of blood. This process is regulated by a complex network of hematopoietic growth factors, including transcription factors, growth factors, and cytokines. These factors stimulate the HSCs to divide and differentiate, though some HSCs remain undifferentiated to maintain a self-renewing pool.
Most HSCs commit to...
Most HSCs commit to...